RYTM Intrinsic Valuation and Fundamental Analysis - Rhythm Pharmaceuticals Inc

	Rhythm Pharmaceuticals Inc NASDAQ:RYTM	US
	RENERGEN Ltd F:9960	ZA
	Select Medical Holdings Corp NYSE:SEM	US

Intrinsic Value

The intrinsic value for Rhythm Pharmaceuticals Inc (RYTM) under the Base Case is 86.8098 USD. Compared with the current market price of 105.9587 USD, the stock appears Overvalued by 18% .

DCF Value

$110.2019

Multiples-Based Value

$63.4177

DCF Value

$110.2019

Multiples-Based Value

$63.4177

DCF suggests undervaluation, while multiples suggest overvaluation.

Why combine DCF with multiples? What is Intrinsic Value?

RYTM Intrinsic Value

Overvaluation 18%

Intrinsic Value

Price $105.9587

Bear Case

Base Case

Bull Case

Track Buy Zone

20% below Intrinsic Value $69.45

Get notified when the price drops into your buy zone

Current Price $105.96

Intrinsic Value $86.81

Margin of Safety 20% $69.45

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Rhythm Pharmaceuticals Inc.

Explain Valuation